236 related articles for article (PubMed ID: 32482173)
21. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Hossain MS; Douglas NM; Humphreys GS; Sibley CH; Guerin PJ; Price RN
Lancet Infect Dis; 2019 Jan; 19(1):91-101. PubMed ID: 30587297
[TBL] [Abstract][Full Text] [Related]
22. Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.
Moore KA; Simpson JA; Paw MK; Pimanpanarak M; Wiladphaingern J; Rijken MJ; Jittamala P; White NJ; Fowkes FJI; Nosten F; McGready R
Lancet Infect Dis; 2016 May; 16(5):576-583. PubMed ID: 26869377
[TBL] [Abstract][Full Text] [Related]
23. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis.
Naing C; Whittaker MA; Htet NH; Aye SN; Mak JW
PLoS One; 2019; 14(12):e0225882. PubMed ID: 31856172
[TBL] [Abstract][Full Text] [Related]
25. Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial.
Muehlenbachs A; Nabasumba C; McGready R; Turyakira E; Tumwebaze B; Dhorda M; Nyehangane D; Nalusaji A; Nosten F; Guerin PJ; Piola P
Malar J; 2012 May; 11():150. PubMed ID: 22554092
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Marwa K; Kapesa A; Baraka V; Konje E; Kidenya B; Mukonzo J; Kamugisha E; Swedberg G
PLoS One; 2022; 17(3):e0264339. PubMed ID: 35271592
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy and safety of the artemisinin derivatives compared to quinine for treating severe malaria in children and adults: A systematic update of literature and network meta-analysis.
Nyaaba N; Andoh NE; Amoh G; Amuzu DSY; Ansong M; Ordóñez-Mena JM; Hirst J
PLoS One; 2022; 17(7):e0269391. PubMed ID: 35857773
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
Piola P; Nabasumba C; Turyakira E; Dhorda M; Lindegardh N; Nyehangane D; Snounou G; Ashley EA; McGready R; Nosten F; Guerin PJ
Lancet Infect Dis; 2010 Nov; 10(11):762-9. PubMed ID: 20932805
[TBL] [Abstract][Full Text] [Related]
30. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
31. Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester.
Clark RL
Birth Defects Res; 2020 Nov; 112(18):1403-1449. PubMed ID: 33079495
[TBL] [Abstract][Full Text] [Related]
32. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
[TBL] [Abstract][Full Text] [Related]
33. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
[TBL] [Abstract][Full Text] [Related]
34. Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort.
Mosha D; Mazuguni F; Mrema S; Sevene E; Abdulla S; Genton B
Malar J; 2014 May; 13():197. PubMed ID: 24884890
[TBL] [Abstract][Full Text] [Related]
35. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data.
WWARN Gametocyte Study Group
BMC Med; 2016 May; 14():79. PubMed ID: 27221542
[TBL] [Abstract][Full Text] [Related]
36. The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.
Kovacs SD; van Eijk AM; Sevene E; Dellicour S; Weiss NS; Emerson S; Steketee R; Ter Kuile FO; Stergachis A
PLoS One; 2016; 11(11):e0164963. PubMed ID: 27824884
[TBL] [Abstract][Full Text] [Related]
37. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.
Augusto O; Stergachis A; Dellicour S; Tinto H; Valá A; Ruperez M; Macete E; Nakanabo-Diallo S; Kazienga A; Valéa I; d'Alessandro U; Ter Kuile FO; Calip GS; Ouma P; Desai M; Sevene E
Malar J; 2020 Apr; 19(1):144. PubMed ID: 32268901
[TBL] [Abstract][Full Text] [Related]
38. Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review.
Saito M; Gilder ME; Nosten F; Guérin PJ; McGready R
Malar J; 2017 Dec; 16(1):491. PubMed ID: 29254487
[TBL] [Abstract][Full Text] [Related]
39. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.
; Dahal P; d'Alessandro U; Dorsey G; Guerin PJ; Nsanzabana C; Price RN; Sibley CH; Stepniewska K; Talisuna AO
BMC Med; 2015 Sep; 13():212. PubMed ID: 26343145
[TBL] [Abstract][Full Text] [Related]
40. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
